A Bioequivalence Study of Recombinant Human Follicle-Stimulating Hormone Injection Versus Recombinant Human Follitropin For Injection in Healthy Chinese Adult Women
The novel prefilled rh-FSH injection (GenSci008) is bioequivalent to the reference formulation (Jinfollin<sup>®</sup>), offering a user-friendly and precise alternative for subcutaneous administration in the treatment of infertility.
Authors
- Wenyuan Xue
- Shujing Jin
- Yixin Zha
- Dongke Zhang (ORCID: https://orcid.org/0000-0003-0715-7986)
- Jigang Zhang (ORCID: https://orcid.org/0000-0003-4532-8379)
- Xiaoyan Zhu (ORCID: https://orcid.org/0000-0002-7998-6444)
- Xueying Ding (ORCID: https://orcid.org/0000-0002-8366-7059)
- Weiwei Gao (ORCID: https://orcid.org/0000-0001-5196-4887)
- Ying Ding (ORCID: https://orcid.org/0000-0002-0172-1091)
- Tianhong Luo
Institutions
- Shanghai Jiao Tong University (CN)
- Changchun Institute of Biological Products (CN)
Publication Details
- Journal
- Drugs in R&D
- Published
- 2025-07-12
- DOI
- https://doi.org/10.1007/s40268-025-00513-w
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00